C Partners Holding’s Pfizer PFE Stock Holding History

C Partners Holding’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,181	Closed	-$133K	–	172
2018 Q3	$133K	Sell	3,181 -3,104	-49%	-$119K	0.05%	48
2018 Q2	$216K	Sell	6,285 -54	-0.9%	-$1.84K	0.08%	188
2018 Q1	$213K	Sell	6,339 -1,550	-20%	-$53.3K	0.09%	147
2017 Q4	$271K	Buy	+7,889	New	+$269K	0.11%	144
2015 Q3	–	Sell	-52,700	Closed	-$1.68M	–	28
2015 Q2	$1.68M	Hold	52,700	–	–	0.79%	29
2015 Q1	$1.74M	Hold	52,700	–	–	0.56%	32
2014 Q4	$1.56M	Buy	+52,700	New	+$1.51M	0.5%	36

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C Partners Holding's PFE Position: Q4 2018 in Review

C Partners Holding sold out of Pfizer (PFE) in Q4 2018, closing a stake of 3,181 shares — an estimated $133K sold.

C Partners Holding first reported a position in PFE in Q4 2014 and held it in 7 quarters. The position peaked at $1.74M in Q1 2015. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

C Partners Holding reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
C Partners Holding sold 3,181 Pfizer shares in Q4 2018, an estimated $133K.
C Partners Holding first reported a position in Pfizer in Q4 2014 and held it in 7 quarters.
C Partners Holding's Pfizer position peaked at $1.74M in Q1 2015.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.